whatsapp-logo+92 300 859 4219 , +92 300 859 1434

   Cash On Delivery is Available

whatsapp-logo+92 300 859 4219 , +92 300 859 1434

   Cash On Delivery is Available

One in 5 sufferers expertise rebound COVID after taking Paxlovid, new examine finds

A brand new examine has discovered that one in 5 people taking Nirmatrelvir-ritonavir remedy, generally generally known as Paxlovid, to deal with extreme signs of COVID-19, skilled a constructive take a look at outcome and shedding of dwell and doubtlessly contagious virus following an preliminary restoration and detrimental take a look at — a phenomenon generally known as virologic rebound. Against this, folks not taking Paxlovid solely skilled rebound about 2 p.c of the time.